Arkaïya is a pioneering platform developing archaea-based diagnostics and therapeutics to support human health, including strains from mother’s milk that enhance immune system development and prevent disease.
Arkaïya, founded in 2022, is a biotechnology platform pioneering the development of archaea-based diagnostics and therapeutics aimed at improving human health and treating diseases. By unlocking the potential of these ancient microorganisms, Arkaïya is redefining the boundaries of modern medicine through innovative, nature-inspired biotechnological solutions.
By integrating data science, computational intelligence, and translational medical research, we develop novel solutions for the critically ill patient.